Literature DB >> 23375927

Long-term follow-up of a pediatric cohort with short QT syndrome.

Juan Villafañe1, Joseph Atallah, Michael H Gollob, Philippe Maury, Christian Wolpert, Roman Gebauer, Hiroshi Watanabe, Minoru Horie, Olli Anttonen, Prince Kannankeril, Brett Faulknier, Jorge Bleiz, Takeru Makiyama, Wataru Shimizu, Robert M Hamilton, Ming-Lon Young.   

Abstract

OBJECTIVES: The purpose of this study was to define the clinical characteristics and long-term follow-up of pediatric patients with short QT syndrome (SQTS).
BACKGROUND: SQTS is associated with sudden cardiac death. The clinical characteristics and long-term prognosis in young patients have not been reported.
METHODS: This was an international case series involving 15 centers. Patients were analyzed for electrocardiography characteristics, genotype, clinical events, Gollob score, and efficacy of medical or defibrillator (implantable cardioverter-defibrillator [ICD]) therapy. To assess the possible prognostic value of the Gollob score, we devised a modified Gollob score that excluded clinical events from the original score.
RESULTS: Twenty-five patients 21 years of age or younger (84% males, median age: 15 years, interquartile range: 9 to 18 years) were followed up for 5.9 years (interquartile range: 4 to 7.1 years). Median corrected QT interval for heart rate was 312 ms (range: 194 to 355 ms). Symptoms occurred in 14 (56%) of 25 patients and included aborted sudden cardiac death in 6 patients (24%) and syncope in 4 patients (16%). Arrhythmias were common and included atrial fibrillation (n = 4), ventricular fibrillation (n = 6), supraventricular tachycardia (n = 1), and polymorphic ventricular tachycardia (n = 1). Sixteen patients (84%) had a familial or personal history of cardiac arrest. A gene mutation associated with SQTS was identified in 5 (24%) of 21 probands. Symptomatic patients had a higher median modified Gollob score (excluding points for clinical events) compared with asymptomatic patients (5 vs. 4, p = 0.044). Ten patients received medical treatment, mainly with quinidine. Eleven of 25 index cases underwent ICD implantation. Two patients had appropriate ICD shocks. Inappropriate ICD shocks were observed in 64% of patients.
CONCLUSIONS: SQTS is associated with aborted sudden cardiac death among the pediatric population. Asymptomatic patients with a Gollob score of <5 remained event free, except for an isolated episode of supraventricular tachycardia, over an average 6-year follow-up. A higher modified Gollob score of 5 or more was associated with the likelihood of clinical events. Young SQTS patients have a high rate of inappropriate ICD shocks.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23375927     DOI: 10.1016/j.jacc.2012.12.025

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

1.  Short QT Syndrome - Review of Diagnosis and Treatment.

Authors:  Boris Rudic; Rainer Schimpf; Martin Borggrefe
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

Review 2.  The renal plumbing system: aquaporin water channels.

Authors:  L N Nejsum
Journal:  Cell Mol Life Sci       Date:  2005-08       Impact factor: 9.261

3.  Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach.

Authors:  Thomas V Karathanos; Patrick M Boyle; Natalia A Trayanova
Journal:  Europace       Date:  2014-11       Impact factor: 5.214

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

Review 5.  Loss of Consciousness in the Young Child.

Authors:  Juan Villafane; Jacob R Miller; Julie Glickstein; Jonathan N Johnson; Jonathan Wagner; Chris S Snyder; Tatiana Filina; Scott L Pomeroy; S Kristen Sexson-Tejtel; Caitlin Haxel; Jason Gottlieb; Pirooz Eghtesady; Devyani Chowdhury
Journal:  Pediatr Cardiol       Date:  2021-01-02       Impact factor: 1.655

Review 6.  Short QT syndrome in pediatrics.

Authors:  Roberta Pereira; Oscar Campuzano; Georgia Sarquella-Brugada; Sergi Cesar; Anna Iglesias; Josep Brugada; Fernando E S Cruz Filho; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2017-03-16       Impact factor: 5.460

7.  Avoiding sports-related sudden cardiac death in children with congenital channelopathy : Recommendations for sports activities.

Authors:  C N Lang; J Steinfurt; K E Odening
Journal:  Herz       Date:  2017-04       Impact factor: 1.443

Review 8.  Epidemiology of inherited arrhythmias.

Authors:  Joost A Offerhaus; Connie R Bezzina; Arthur A M Wilde
Journal:  Nat Rev Cardiol       Date:  2019-10-03       Impact factor: 32.419

9.  Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis.

Authors:  Carlos Iribarren; Alfred D Round; Jonathan A Peng; Meng Lu; Arthur L Klatsky; Jonathan G Zaroff; Taylor J Holve; Amit Prasad; Paul Stang
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-05-14       Impact factor: 1.468

10.  The Pharmacogenomics of a Mutation 'Hotspot' for the Short QT Syndrome.

Authors:  Dawood Darbar; Mark McCauley
Journal:  JACC Clin Electrophysiol       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.